🇺🇸 Ginkgo biloba in United States

1,348 US adverse-event reports

Marketing authorisation

FDA

  • Status: approved

Safety signals — FAERS

Adverse reaction reports describe suspected side effects. A report does not mean the drug caused the event — co-medications, underlying disease and coincidence all contribute.

Most-reported reactions

  1. Fatigue — 164 reports (12.17%)
  2. Dizziness — 153 reports (11.35%)
  3. Nausea — 146 reports (10.83%)
  4. Headache — 143 reports (10.61%)
  5. Drug Ineffective — 137 reports (10.16%)
  6. Fall — 137 reports (10.16%)
  7. Drug Interaction — 131 reports (9.72%)
  8. Diarrhoea — 119 reports (8.83%)
  9. Asthenia — 115 reports (8.53%)
  10. Pain — 103 reports (7.64%)

Source database →

Ginkgo biloba in other countries

Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.

Frequently asked questions

Is Ginkgo biloba approved in United States?

Yes. FDA has authorised it.

Who is the marketing authorisation holder for Ginkgo biloba in United States?

University Hospital, Basel, Switzerland is the originator. The local marketing authorisation holder may differ — check the official source linked above.